Liang Cheng, Vice Chair for Translational Research at Warren Alpert Medical School of Brown University, President of the International Society of Urologic Pathology, shared a post on LinkedIn about recent paper he and colleagues co-authored published in Italian Archives of Urology and Andrology.

“Should pathologists and clinicians continue to consider Grade Group 1 (Gleason score ≤6) prostate cancer as a true carcinoma?

Let’s hear from patient advocates – PubMed – an excellent and insightful editorial from Prof. Montironi.”

Title: Should pathologists and clinicians continue to consider Grade Group 1 (Gleason score ≤6) prostate cancer as a true carcinoma? Let’s hear from patient advocates

Authors: Rodolfo Montironi, Alessia Cimadamore, Antonio Lopez-Beltran, Eamonn T. Rogers, Liang Cheng

Read The Full Article at Italian Archives of Urology and Andrology.

Liang Cheng: Should Pathologists Continue to Consider Grade Group 1 Prostate Cancer as a True Carcinoma?

More posts featuring Liang Cheng.